the pharmaletter | chinese answer to alzheimer's puzzle?-wepoker官网

about us

green valley is an innovative chinese pharmaceutical company that pioneers carbohydrate drugs development and manufacturing in the world.

about green valley

our business

mission & vision

our culture

code of business ethics

gv-971

here you can get access to more information of gv-971.

products

news reports

research highlights

milestones

scientific research information

originality is the soul of our innovation in scientific research. we are devoted to developing drugs and healthcare solutions that patients are in the greatest need of.

life sciences innovation

research parteners

news

here you can get access to the latest news reports of green valley.

press releases

news reports

social responsibility

careers

apart from the competitive compensation & benefits programs, we have developed a detailed benefits and perks scheme. we respect, appreciate and reward the contributions of every employee for their hard work and dedication.

salary and benefits

media contacts

wepoker-微扑克官网-纵横扑克之道

features

the pharmaletter | chinese answer to alzheimer's puzzle?

date：2018-10-30

evidence of an effective new treatment for alzheimer’s would create shock waves across healthcare given the extent of the global need among millions of patients.

but it could also be a major event in geopolitics, given what making progress in this highly complex disease would say about a country’s scientific capabilities.

so it is potentially significant that a chinese company, green valley pharmaceutical, has achieved the rare feat of getting a positive read-out in a phase iii trial in mild-to-moderate alzheimer's disease.

"gv-971 could help diversify the portfolio of treatments for this terrible disease"

full story here:

shareto：

alzforum | fits and starts: trial results from the ctad conference

medscape news | positive topline results for novel alzheimer's drug